Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
•
Benign Hematology
•
Thalassemia
How do you counsel patients with transfusion dependent beta thalassemia about luspatercept?
Related Questions
How do you manage arthritis resulting from deferiprone in transfusion dependent thalassemia?
Are there any circumstances where you would consider bridging for patients on DOACs?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Is there a correlation between spleen size and degree of thrombocytopenia?
How do you manage mild Type 1 von Willebrand disease undergoing wisdom teeth removal?
Is there any indication for hydroxyurea in patients with sickle cell trait?
What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?
How do you interpret a low VWF activity/antigen ratio, when both activity and antigen levels are above 50%?
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
Are SCDs contraindicated in patients with acute DVTs?
